Decipher Labs Ltd.
BSE: DECIPHER
Prev Close
10.67
Open Price
10.73
Volume
6,066
Today Low / High
10.37 / 11.12
52 WK Low / High
9.61 / 17.25
Range
10 - 11
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 10.9, reflecting a change of 0.23 (2.15558%). The expected target range on the BSE is 10 - 11. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Decipher Labs Ltd. Graph
Decipher Labs Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Decipher Labs Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 10.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 10.90 | 11.01 | 9.91 - 12.11 |
| 11.12 | 8.89 - 13.34 | ||
| 11.23 | 7.86 - 14.60 | ||
| Bearish Scenario | 10.90 | 10.79 | 9.71 - 11.87 |
| 10.68 | 8.55 - 12.82 | ||
| 10.57 | 7.40 - 13.74 |
Overview of Decipher Labs Ltd.
ISIN
INE643N01012
Industry
Medical - Pharmaceuticals
Vol.Avg
7,913
Market Cap
110,999,000
Last Dividend
0
Official Website
IPO Date
DCF Diff
15.98
DCF
-5
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 22.61 Cr | 0.67 Cr | 21.94 Cr | 0.9703 | 0.00 Cr | 0.00 Cr | -7.70 Cr | -5.08 Cr | -5.06 | -5.91 Cr | -0.2247 |
| 2024-03-31 | 36.28 Cr | 3.14 Cr | 33.14 Cr | 0.9135 | 0.00 Cr | 3.75 Cr | -0.30 Cr | -1.68 Cr | -1.66 | -0.27 Cr | -0.0462 |
| 2023-03-31 | 45.57 Cr | 0.52 Cr | 45.06 Cr | 0.9887 | 0.07 Cr | 41.19 Cr | 2.83 Cr | -2.68 Cr | -2.66 | 2.89 Cr | -0.0589 |
| 2022-03-31 | 65.32 Cr | 0.16 Cr | 65.17 Cr | 0.9976 | 0.00 Cr | 0.37 Cr | 12.52 Cr | 11.38 Cr | 11.27 | 13.30 Cr | 0.1743 |
| 2021-03-31 | 55.56 Cr | 1.10 Cr | 54.46 Cr | 0.9802 | 0.03 Cr | 1.58 Cr | 3.40 Cr | 1.40 Cr | 1.39 | 3.46 Cr | 0.0252 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.81 Cr | 25.76 Cr | 2.91 Cr | 22.8557 Cr | 0.24 Cr | -2.56 Cr | 0.00 Cr | 0.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 2.9091 Cr |
| 2024-03-31 | 9.31 Cr | 33.63 Cr | 11.77 Cr | 21.8606 Cr | 0.00 Cr | -9.31 Cr | 0.00 Cr | 0.88 Cr | 0.00 Cr | 0.00 Cr | 5.49 Cr | 11.7725 Cr |
| 2023-03-31 | 7.42 Cr | 28.16 Cr | 4.96 Cr | 23.2085 Cr | 0.95 Cr | -6.47 Cr | 0.00 Cr | 0.97 Cr | 0.00 Cr | 0.00 Cr | 3.76 Cr | 4.9560 Cr |
| 2022-03-31 | 15.41 Cr | 41.95 Cr | 17.78 Cr | 24.1652 Cr | 10.32 Cr | -5.09 Cr | 0.04 Cr | 0.33 Cr | 0.00 Cr | 0.00 Cr | 0.26 Cr | 11.1086 Cr |
| 2021-03-31 | 6.98 Cr | 38.72 Cr | 25.03 Cr | 13.6874 Cr | 16.39 Cr | 9.41 Cr | 0.04 Cr | 1.72 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 17.3077 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -9.8182 Cr | 3.0683 Cr | 0.2445 Cr | -9.8751 Cr | -6.5054 Cr | 2.8084 Cr | -0.0569 Cr | -6.3862 Cr | 0.2445 Cr | 0.0000 Cr | 0.0000 Cr |
| 2024-03-31 | 4.8541 Cr | -1.7910 Cr | -1.1670 Cr | 4.7957 Cr | 1.8961 Cr | 9.3138 Cr | -0.0584 Cr | -1.6756 Cr | -0.9494 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | -1.5648 Cr | -4.2757 Cr | -2.1504 Cr | -2.3478 Cr | -7.9909 Cr | 7.4177 Cr | -0.7830 Cr | -2.6823 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr |
| 2022-03-31 | 8.2648 Cr | -0.4533 Cr | 1.3010 Cr | 8.0656 Cr | 8.4328 Cr | 15.4086 Cr | -0.1992 Cr | 11.3838 Cr | 1.7777 Cr | 0.0000 Cr | 0.0000 Cr |
| 2021-03-31 | 1.8323 Cr | -0.3137 Cr | 3.9888 Cr | 1.5186 Cr | 5.5074 Cr | 6.9758 Cr | -0.3137 Cr | 1.4026 Cr | 4.9206 Cr | 0.0000 Cr | 0.2745 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 5.80 Cr | 0.15 Cr | 5.65 Cr | 0.9742 | -0.75 Cr | -0.59 Cr | -0.59 | -0.46 Cr | -0.1021 |
| 2024-09-30 | 5.87 Cr | 0.00 Cr | 5.87 Cr | 1.0000 | -1.45 Cr | -1.33 Cr | -1.31 | -1.21 Cr | -0.2264 |
| 2024-06-30 | 7.44 Cr | 0.29 Cr | 7.15 Cr | 0.9607 | 1.36 Cr | 0.95 Cr | 0.94 | 1.47 Cr | 0.1272 |
| 2024-03-31 | 10.59 Cr | 3.14 Cr | 7.45 Cr | 0.7037 | 2.22 Cr | 1.20 Cr | 1.19 | 2.03 Cr | 0.1138 |
| 2023-12-31 | 8.29 Cr | 0.00 Cr | 8.29 Cr | 1.0000 | 0.01 Cr | 0.01 Cr | 0.01 | 0.03 Cr | 0.0013 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 4.93 Cr | 0.03 Cr | 4.97 Cr | 0.00 Cr | 0.00 Cr | 21.99 Cr | 0.88 Cr | 30.57 Cr | 9.04 Cr |
| 2024-06-30 | -9.31 Cr | 18.63 Cr | 9.31 Cr | 0.00 Cr | 0.00 Cr | 9.31 Cr | 0.00 Cr | 0.00 Cr | -21.86 Cr |
| 2024-03-31 | 9.31 Cr | 0.00 Cr | 9.31 Cr | 7.80 Cr | 0.00 Cr | 24.68 Cr | 0.88 Cr | 33.63 Cr | 11.77 Cr |
| 2023-12-31 | -8.19 Cr | 16.38 Cr | 8.19 Cr | 0.00 Cr | 0.00 Cr | 8.19 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 8.19 Cr | 0.00 Cr | 8.19 Cr | 5.93 Cr | 0.00 Cr | 16.91 Cr | 0.93 Cr | 23.93 Cr | 3.33 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.95 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 1.20 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | -1.94 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-06-30 | -0.95 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: female
Year Born: 1971
Gender: male
Year Born: 1980
Gender: female
Year Born:
Gender: female
Year Born: 1992
Gender: Not Specified
Year Born: 1965
FAQs about Decipher Labs Ltd.
The CEO is Sushant Mohan Lal.
The current price is ₹10.99.
The range is ₹9.61-17.25.
The market capitalization is ₹11.10 crores.
The P/E ratio is 47.83.
The company operates in the Healthcare sector.
Overview of Decipher Labs Ltd. (ISIN: INE643N01012) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹11.10 crores and an average daily volume of 7,913 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.